Predicting Antiseizure Medication Treatment in Children with Rare Tuberous Sclerosis Complex–Related Epilepsy Using Deep Learning

References

1. 1.↵
   2. Randle SC

   . Tuberous sclerosis complex: a review. Pediatr Ann 2017;46:e166–171 doi:10.3928/19382359-20170320-01 pmid:28414398

   CrossRefPubMed
2. 2.↵
   2. Holmes GL,
   3. Stafstrom CE

   ; Tuberous Sclerosis Study Group. Tuberous sclerosis complex and epilepsy: recent developments and future challenges. Epilepsia 2007;48:617–30 doi:10.1111/j.1528-1167.2007.01035.x pmid:17386056

   CrossRefPubMedWeb of Science
3. 3.↵
   2. Chu-Shore CJ,
   3. Major P,
   4. Camposano S, et al

   . The natural history of epilepsy in tuberous sclerosis complex. Epilepsia 2010;51:1236–41 doi:10.1111/j.1528-1167.2009.02474.x pmid:20041940

   CrossRefPubMedWeb of Science
4. 4.↵
   2. Słowińska M,
   3. Jóźwiak S,
   4. Peron A, et al

   . Early diagnosis of tuberous sclerosis complex: a race against time—how to make the diagnosis before seizures? Orphanet J Rare Dis 2018;13:25 doi:10.1186/s13023-018-0764-z pmid:29378663

   CrossRefPubMed
5. 5.↵
   2. Henske EP,
   3. Jóźwiak S,
   4. Kingswood JC, et al

   . Tuberous sclerosis complex. Nat Rev Dis Primers 2016;2:16035 doi:10.1038/nrdp.2016.35 pmid:27226234

   CrossRefPubMed
6. 6.↵
   2. Strzelczyk A,
   3. Rosenow F,
   4. Zollner JP, et al

   . Epidemiology, healthcare resource use, and mortality in patients with tuberous sclerosis complex: a population-based study on German health insurance data. Seizure 2021;91:287–95 doi:10.1016/j.seizure.2021.06.027 pmid:34265583

   CrossRefPubMed
7. 7.↵
   2. Jansen FE,
   3. van Huffelen AC,
   4. Bourez-Swart M, et al

   . Consistent localization of interictal epileptiform activity on EEGs of patients with tuberous sclerosis complex. Epilepsia 2005;46:415–19 doi:10.1111/j.0013-9580.2005.31704.x pmid:15730539

   CrossRefPubMed
8. 8.↵
   2. Curatolo P,
   3. Nabbout R,
   4. Lagae L, et al

   . Management of epilepsy associated with tuberous sclerosis complex: updated clinical recommendations. Eur J Paediatr Neurol 2018;22:738–48 doi:10.1016/j.ejpn.2018.05.006 pmid:29880258

   CrossRefPubMed
9. 9.↵
   2. van der Poest Clement E,
   3. Jansen FE,
   4. Braun KP, et al

   . Update on drug management of refractory epilepsy in tuberous sclerosis complex. Paediatr Drugs 2020;22:73–84 doi:10.1007/s40272-019-00376-0 pmid:31912454

   CrossRefPubMed
10. 10.↵
    2. Jesmanas S,
    3. Norvainytė K,
    4. Gleiznienė R, et al

    . Different MRI-defined tuber types in tuberous sclerosis complex: quantitative evaluation and association with disease manifestations. Brain Dev 2018;40:196–204 doi:10.1016/j.braindev.2017.11.010 pmid:29258718

    CrossRefPubMed
11. 11.↵
    2. Tong XZ,
    3. Wang XF,
    4. Qin L, et al

    . Vagus nerve stimulation for drug-resistant epilepsy induced by tuberous sclerosis complex. Epilepsy Behav 2022;126:108431 doi:10.1016/j.yebeh.2021.108431 pmid:34883463

    CrossRefPubMed
12. 12.↵
    2. Yang J,
    3. Zhao C,
    4. Su S, et al

    . Machine Learning in Epilepsy Drug Treatment Outcome Prediction Using Multi-modality Data in Children with Tuberous Sclerosis Complex. In: 2020 6th International Conference on Big Data and Information Analytics (BigDIA). December 4-6, 2020. Shenzhen, China doi:10.1109/BigDIA51454.2020.00024
13. 13.↵
    2. Russo C,
    3. Nastro A,
    4. Cicala D, et al

    . Neuroimaging in tuberous sclerosis complex. Childs Nerv Syst 2020;36:2497–509 doi:10.1007/s00381-020-04705-4 pmid:32519125

    CrossRefPubMed
14. 14.↵
    2. Sanchez Fernandez I,
    3. Yang E,
    4. Calvachi P, et al

    ; TACERN Study Group. Deep learning in rare disease: detection of tubers in tuberous sclerosis complex. PLoS One 2020;15:e0232376 doi:10.1371/journal.pone.0232376 pmid:32348367

    CrossRefPubMed
15. 15.↵
    2. Hu J,
    3. Qing Z,
    4. Liu R, et al

    . Deep learning-based classification and voxel-based visualization of frontotemporal dementia and Alzheimer's disease. Front Neurosci 2020;14:626154 doi:10.3389/fnins.2020.626154 pmid:33551735

    CrossRefPubMed
16. 16.↵
    2. Spasov S,
    3. Passamonti L,
    4. Duggento A, et al

    ; Alzheime's Disease Neuroimaging Initiative. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease. Neuroimage 2019;189:276–87 doi:10.1016/j.neuroimage.2019.01.031 pmid:30654174

    CrossRefPubMed
17. 17.↵
    2. Kim H,
    3. Lee Y,
    4. Kim YH, et al

    . Deep learning-based method to differentiate neuromyelitis optica spectrum disorder from multiple sclerosis. Front Neurol 2020;11:599042 doi:10.3389/fneur.2020.599042 pmid:33329357

    CrossRefPubMed
18. 18.↵
    2. Eweje FR,
    3. Bao B,
    4. Wu J, et al

    . Deep learning for classification of bone lesions on routine MRI. EBioMedicine 2021;68:103402 doi:10.1016/j.ebiom.2021.103402 pmid:34098339

    CrossRefPubMed
19. 19.↵
    2. Grossman R,
    3. Haim O,
    4. Abramov S, et al

    . Differentiating small-cell lung cancer from non-small-cell lung cancer brain metastases based on MRI using efficientnet and transfer learning approach. Technol Cancer Res Treat 2021;20:153303382110049 doi:10.1177/15330338211004919 pmid:34030542

    CrossRefPubMed
20. 20.↵
    2. Jonsson BA,
    3. Bjornsdottir G,
    4. Thorgeirsson TE, et al

    . Brain age prediction using deep learning uncovers associated sequence variants. Nat Commun 2019;10:5409 doi:10.1038/s41467-019-13163-9 pmid:31776335

    CrossRefPubMed
21. 21.↵
    2. Peng H,
    3. Gong W,
    4. Beckmann CF, et al

    . Accurate brain age prediction with lightweight deep neural networks. Med Image Anal 2021;68:101871 doi:10.1016/j.media.2020.101871 pmid:33197716

    CrossRefPubMed
22. 22.↵
    2. An S,
    3. Malhotra K,
    4. Dilley C, et al

    . Predicting drug-resistant epilepsy: a machine learning approach based on administrative claims data. Epilepsy Behav 2018;89:118–25 doi:10.1016/j.yebeh.2018.10.013 pmid:30412924

    CrossRefPubMed
23. 23.↵
    2. Luckett PH,
    3. Maccotta L,
    4. Lee JJ, et al

    . Deep learning resting state fMRI lateralization of temporal lobe epilepsy. Epilepsia 2022;63:1542–52 doi:10.1111/epi.17233 pmid:35320587

    CrossRefPubMed
24. 24.↵
    2. Gleichgerrcht E,
    3. Munsell B,
    4. Bhatia S, et al

    . Deep learning applied to whole-brain connectome to determine seizure control after epilepsy surgery. Epilepsia 2018;59:1643–54 doi:10.1111/epi.14528 pmid:30098002

    CrossRefPubMed
25. 25.↵
    2. Zhang Q,
    3. He Y,
    4. Qu T, et al

    . Delayed brain development of Rolandic epilepsy profiled by deep learning-based neuroanatomic imaging. Eur Radiol 2021;31:9628–37 doi:10.1007/s00330-021-08048-9 pmid:34018056

    CrossRefPubMed
26. 26.↵
    2. He K,
    3. Zhang X,
    4. Ren S, et al

    . Deep residual learning for image recognition. In: Proceedings of the IEEE Conference on Computer Vision and Pattern Recognition. June 27–30, 2016. Las Vagas, Nevada
27. 27.↵
    2. Cole JH,
    3. Poudel RP,
    4. Tsagkrasoulis D, et al

    . Predicting brain age with deep learning from raw imaging data results in a reliable and heritable biomarker. Neuroimage 2017;163:115–24 doi:10.1016/j.neuroimage.2017.07.059 pmid:28765056

    CrossRefPubMed
28. 28.↵
    2. Meyer A,
    3. Chlebus G,
    4. Rak M, et al

    . Anisotropic 3D multi-stream CNN for accurate prostate segmentation from multi-planar MRI. Comput Methods Programs Biomed 2021;200:105821 doi:10.1016/j.cmpb.2020.105821 pmid:33218704

    CrossRefPubMed
29. 29.↵
    2. Folego G,
    3. Weiler M,
    4. Casseb RF, et al

    . Alzheimer's disease detection through whole-brain 3D-CNN MRI. Front Bioeng Biotechnol 2020;8:534592 doi:10.3389/fbioe.2020.534592 pmid:33195111

    CrossRefPubMed
30. 30.↵
    2. Grilli G,
    3. Moffa AP,
    4. Perfetto F, et al

    . Neuroimaging features of tuberous sclerosis complex and Chiari type I malformation: a rare association. J Pediatr Neurosci 2018;13:224–28 doi:10.4103/jpn.JPN_76_17 pmid:30090143

    CrossRefPubMed
31. 31.↵
    2. Wiggermann V,
    3. Hernandez-Torres E,
    4. Traboulsee A, et al

    . FLAIR2: a combination of FLAIR and T2 for lmproved MS lesion detection. AJNR Am J Neuroradiol 2016;37:259–65 doi:10.3174/ajnr.A4514 pmid:26450539

    Abstract/FREE Full Text
32. 32.↵
    2. Gabr RE,
    3. Hasan KM,
    4. Haque ME, et al

    . Optimal combination of FLAIR and T2-weighted MRI for improved lesion contrast in multiple sclerosis. J Magn Reson Imaging 2016;44:1293–300 doi:10.1002/jmri.25281 pmid:27126898

    CrossRefPubMed
33. 33.↵
    2. Liang G,
    3. Xing X,
    4. Liu L, et al

    . Alzheimer's disease classification using 2D convolutional neural networks. Annu Int Conf IEEE Eng Med Biol Soc 2021;2021:3008–12 doi:10.1109/EMBC46164.2021.9629587 pmid:34891877

    CrossRefPubMed
34. 34.↵
    2. Jiang D,
    3. Liao J,
    4. Zhao C, et al

    . Recognizing pediatric tuberous sclerosis complex based on multi-contrast MRI and deep weighted fusion network. Bioengineering (Basel) 2023;10:870 doi:10.3390/bioengineering10070870 pmid:37508897

    CrossRefPubMed
35. 35.↵
    2. Hu Z,
    3. Jiang D,
    4. Zhao X, et al

    . Predicting drug treatment outcomes in childrens with tuberous sclerosis complex–related epilepsy: a clinical radiomics study. AJNR Am J Neuroradiol 2023;44:853–60 doi:10.3174/ajnr.A7911 pmid:37348968

    Abstract/FREE Full Text
36. 36.↵
    2. Shinnar S

    . The new ILAE classification. Epilepsia 2010;51:715–17 doi:10.1111/j.1528-1167.2010.02542.x pmid:20394644

    CrossRefPubMedWeb of Science
37. 37.↵
    2. Tan M,
    3. Efficientnet LQ

    . Rethinking model scaling for convolutional neural networks. In: Thirty-Sixth International Conference on Machine Learning. June 9-15, 2019. Long Beach, California
38. 38.↵
    2. Jenkinson M,
    3. Beckmann CF,
    4. Behrens TE, et al

    . FSL. Neuroimage 2012;62:782–90 doi:10.1016/j.neuroimage.2011.09.015 pmid:21979382

    CrossRefPubMedWeb of Science
39. 39.↵
    2. Isensee F,
    3. Schell M,
    4. Pflueger I, et al

    . Automated brain extraction of multisequence MRI using artificial neural networks. Hum Brain Mapp 2019;40:4952–64 doi:10.1002/hbm.24750 pmid:31403237

    CrossRefPubMed
40. 40.↵
    2. Hsieh DT,
    3. Jennesson MM,
    4. Thiele EA

    . Epileptic spasms in tuberous sclerosis complex. Epilepsy Res 2013;106:200–10 doi:10.1016/j.eplepsyres.2013.05.003 pmid:23796861

    CrossRefPubMed
41. 41.↵
    2. Lyu Q,
    3. Shan H,
    4. Steber C, et al

    . Multi-contrast super-resolution MRI through a progressive network. IEEE Trans Med Imaging 2020;39:2738–49 doi:10.1109/TMI.2020.2974858 pmid:32086201

    CrossRefPubMed
42. 42.↵
    2. Jaworek-Korjakowska J,
    3. Brodzicki A,
    4. Cassidy B, et al

    . Interpretability of a deep learning based approach for the classification of skin lesions into main anatomic body sites. Cancers (Basel) 2021;13:6048 doi:10.3390/cancers13236048 pmid:34885158

    CrossRefPubMed
43. 43.↵
    2. Gül Mert G,
    3. Altunbaşak Ş,
    4. Hergüner Ö, et al

    . Factors affecting epilepsy prognosis in patients with tuberous sclerosis. Childs Nerv Syst 2019;35:463–68 doi:10.1007/s00381-019-04066-7 pmid:30673834

    CrossRefPubMed
44. 44.↵
    2. Kwan P,
    3. Brodie MJ

    . Early identification of refractory epilepsy. N Engl J Med 2000;342:314–19 doi:10.1056/NEJM200002033420503 pmid:10660394

    CrossRefPubMedWeb of Science
45. 45.↵
    2. Jeong A,
    3. Nakagawa JA,
    4. Wong M

    . Predictors of drug-resistant epilepsy in tuberous sclerosis complex. J Child Neurol 2017;32:1092–98 doi:10.1177/0883073817737446 pmid:29129154

    CrossRefPubMed
46. 46.
    2. Simonyan K,
    3. Zisserman A

    . Very deep convolutional networks for large-scale image recognition. arXiv 2014;1409:1556 doi:10.48550/arXiv.1409.1556

    CrossRef
47. 47.
    2. Szegedy C,
    3. Liu W,
    4. Jia Y, et al

    . Going deeper with convolutions. arXiv 2014;1409:4802–98 doi:10.48550/arXiv.1409.4842

    CrossRef